- Home
- / Longeveron
Longeveron
Stock Price
$2.2
2024-10-29
Market Capitalization
$31.4 M
2024-10-29
Revenue
$1.2 M
FY, 2025
Longeveron Summary
Company Summary
- Overview
- Longeveron is a life-sciences company that develops biological solutions for aging and aging-associated diseases. Its investigational product candidate (LMSC) is based on a specialized cell known as a mesenchymal stem cell that is derived from the bone marrow of healthy young adult donors.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- Miami, FL, US | view all locations
- Website
- http://longeveron.com/
- Cybersecurity rating
Table of Contents
Key People
Paul Lehr, International Executive Director, General Counsel and Secretary
Lisa McClain-Moss, Senior Director, Manufacturing
Joshua M. Hare, Co-Founder, Chief Science Officer and Chairman
Operating MetricsView all
Manufacturing Facility Space, sq. ft.
4.2K
Feb, 2021
Cleanroom Space, sq. ft
3K
Feb, 2021
Warehouse Space, sq. ft.
1.2K
Feb, 2021
LocationsView all
1 location detected
Miami, FL HQ
United States
1951 NW 7th Ave #520
Longeveron Financials
Summary Financials
- Revenue (Q1, 2026)
- $398.0K
- Gross profit (Q1, 2026)
- $264.0K
- Cash (Q1, 2026)
- $15.8M
- EBIT (Q1, 2026)
- ($4.8M)
- Enterprise value
- $16.4M